Tiny Chains, Big Changes? What FDA’s Latest Actions Mean for Peptide Compounding

Key Takeaways – FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. An additional five peptides will be considered at a PCAC meeting to be held before the end of Feb. 2027….
By: Polsinelli